In concordance with our findings in AML cell lines, the protein levels of Ki67 were significantly reduced and the protein levels of CXCR4 were increased in CD69highCD34+CD38− populations from primary AML patients (Additional file 1: Fig. S7a-c). This evidence concerns the gene MKI67 and acute myeloid leukemia.